Apelin-36 Protects HT22 Cells Against Oxygen-Glucose Deprivation/Reperfusion-Induced Oxidative Stress and

Ziqi Shao1, Shanshan Dou2, Junge Zhu3

  • 1Cheeloo College of Medicine, Shandong University, Jinan, 250014, China.

Neurotoxicity Research
|February 13, 2021
PubMed

Insights

Apelin-36 protects against cerebral ischemia/reperfusion (I/R) injury by reducing oxidative stress and mitochondrial dysfunction. It activates SIRT1-mediated mitophagy, offering neuroprotection in neuronal apoptosis models.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Biochemistry

Background:

  • Cerebral ischemia/reperfusion (I/R) injury involves oxidative stress, mitochondrial dysfunction, and neuronal apoptosis.
  • Mitophagy is crucial for clearing damaged mitochondria.
  • Apelin-36, a neuropeptide, shows potential in protecting against cerebral I/R injury, but its mechanisms require clarification.

Purpose of the Study:

  • To investigate the effects of Apelin-36 on oxidative stress and mitochondrial dysfunction in cerebral I/R injury.
  • To elucidate the role of mitophagy and the SIRT1 pathway in Apelin-36's neuroprotective effects.

Main Methods:

  • Established an oxygen-glucose deprivation/reperfusion (OGD/R) model in HT22 cells.
  • Assessed cell viability, apoptosis, reactive oxygen species (ROS), malondialdehyde (MDA), antioxidant enzymes (SOD, GSH), mitochondrial membrane potential (MMP), and apoptosis-related proteins (Bcl-2, Bax, Cytochrome c, Caspases).
  • Investigated mitophagy markers (p62, LC3B-II, Beclin1) and the involvement of SIRT1, PINK1, and Parkin, using specific inhibitors (EX527, CsA).

Main Results:

  • Apelin-36 improved cell viability, reduced apoptosis, and modulated Bcl-2/Bax ratio in OGD/R-injured cells.
  • Apelin-36 inhibited oxidative stress by decreasing ROS and MDA levels and iNOS expression, while increasing SOD and GSH.
  • Apelin-36 preserved mitochondrial function, evidenced by increased MMP and reduced levels of Cytochrome c, Cleaved caspase-9, and Cleaved caspase-3.
  • Apelin-36 activated SIRT1-mediated PINK1/Parkin-dependent mitophagy, indicated by altered p62, LC3B-II, and Beclin1 levels.
  • Inhibitors of SIRT1 (EX527) and mitophagy (CsA) reversed the protective effects of Apelin-36 on oxidative stress and mitochondrial dysfunction.

Conclusions:

  • Apelin-36 exerts neuroprotective effects against OGD/R-induced injury by mitigating oxidative stress and mitochondrial dysfunction.
  • The protective mechanism involves the activation of SIRT1-mediated PINK1/Parkin-dependent mitophagy.
  • Apelin-36 represents a potential therapeutic agent for cerebral I/R injury.